These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6112211)

  • 21. [Penetration, permeation and resorption of heparin. In vivo studies on human skin].
    Zesch A; Schaefer H
    Arzneimittelforschung; 1976; 26(7):1365-8. PubMed ID: 1036927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological activity and local and systemic tolerance of topically applied iloprost.
    Kecskér A; Blitstein-Willinger E
    Arzneimittelforschung; 1993 Apr; 43(4):450-4. PubMed ID: 7684225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin permeation, biodistribution, and expression of topically applied plasmid DNA.
    Kang MJ; Kim CK; Kim MY; Hwang TS; Kang SY; Kim WK; Ko JJ; Oh YK
    J Gene Med; 2004 Nov; 6(11):1238-46. PubMed ID: 15459965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Aspects of tolerance to transdermal systems from the dermatologic viewpoint].
    Zesch A
    Arzneimittelforschung; 1989 Nov; 39(11A):1497-500. PubMed ID: 2696466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects.
    Benfeldt E
    Acta Derm Venereol Suppl (Stockh); 1999; 206():1-59. PubMed ID: 10605601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pickering w/o emulsions: drug release and topical delivery.
    Frelichowska J; Bolzinger MA; Valour JP; Mouaziz H; Pelletier J; Chevalier Y
    Int J Pharm; 2009 Feb; 368(1-2):7-15. PubMed ID: 18992799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulatory effect of topical application of caffeine on UVB-induced apoptosis in mouse skin.
    Lu YP; Lou YR; Li XH; Xie JG; Lin Y; Shih WJ; Conney AH
    Oncol Res; 2002; 13(2):61-70. PubMed ID: 12392153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Local and transcutaneous pharmacotherapy. Pharmacokinetic principles and clinical evaluation].
    Stüttgen G; Täuber U; Bauer E; Zesch A
    Hautarzt; 1986 Feb; 37(2):65-76. PubMed ID: 3957664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heparin and mucopolysaccharide polysulfuric acid ester permeate human skin].
    Stüttgen G; Panse P; Bauer E
    Z Hautkr; 1989 Sep; 64(9):756, 761-2, 765. PubMed ID: 2530708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pimecrolimus permeates less than tacrolimus through normal, inflamed, or corticosteroid-pretreated skin.
    Meingassner JG; Aschauer H; Stuetz A; Billich A
    Exp Dermatol; 2005 Oct; 14(10):752-7. PubMed ID: 16176283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of membrane-solvent-solute interactions on solute permeation in skin.
    Dias M; Hadgraft J; Lane ME
    Int J Pharm; 2007 Aug; 340(1-2):65-70. PubMed ID: 17467936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption.
    Pariser D
    Am J Ther; 2009; 16(3):264-73. PubMed ID: 19262357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of diethylcarbamazine citrate, antihistamines and corticosteroid derivatives on skin reactivity to Onchocerca supernatants.
    Titanji VP; Barla E; Anyangwe S; Ngu JL
    Tropenmed Parasitol; 1983 Mar; 34(1):30-2. PubMed ID: 6133383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The pharmacokinetics of light-protective agents by photoacoustic spectroscopy].
    Kölmel KF; Sennhenn B; Rohr M; Giese K
    Hautarzt; 1988 Nov; 39(11):731-5. PubMed ID: 3243714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antihistamine drugs in the treatment of allergic skin diseases].
    Kaszuba A
    Pol Merkur Lekarski; 2003 Jun; 14(84):640-6. PubMed ID: 14524291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a multilamellar emulsion on glucocorticoid-induced epidermal atrophy and barrier impairment.
    Ahn SK; Bak HN; Park BD; Kim YH; Youm JK; Choi EH; Hong SP; Lee SH
    J Dermatol; 2006 Feb; 33(2):80-90. PubMed ID: 16556273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical management of cutaneous sulfur mustard injuries.
    Graham JS; Stevenson RS; Mitcheltree LW; Hamilton TA; Deckert RR; Lee RB; Schiavetta AM
    Toxicology; 2009 Sep; 263(1):47-58. PubMed ID: 18762227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery.
    Förster M; Bolzinger MA; Fessi H; Briançon S
    Eur J Dermatol; 2009; 19(4):309-23. PubMed ID: 19443302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Choosing topical corticosteroids.
    Ference JD; Last AR
    Am Fam Physician; 2009 Jan; 79(2):135-40. PubMed ID: 19178066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: in vitro study.
    Prasad R; Koul V; Anand S; Khar RK
    Int J Pharm; 2007 Mar; 333(1-2):70-8. PubMed ID: 17116378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.